Viacoram® Approved in Canada for Treatment in Hypertension

Viacoram® received approval by Health Canada as a first line treatment for mild to moderate hypertension.
According to Dr. Ross Feldman, member and past chair of the Canadian Hypertension Education Program (CHEP) and an investigator in the clinical development of Viacoram® in Canada:

Despite our recent progress, hypertension remains a leading risk for premature death in Canada.  Although we have known for several years that an angiotensin converting enzyme inhibitor paired with a calcium channel blocker is the best one-two punch for knocking down hypertension-related heart disease, Canadians have not had access to such therapy.  The availability of Viacoram® changes that and offers us a very important new weapon in the battle against hypertension and related heart disease and stroke.

Click here to view the full press release.